Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 4,775,597	$ 2,977,713
Marketable securities	0	2,976,573
Accounts receivable, net of allowance for credit losses of $10,000, respectively	550,969	312,664
Accounts receivable, related party net	3,013	0
Prepaid expenses and other current assets	646,130	517,785
Inventories	3,711,636	2,638,186
Advances on contracts	1,011,306	1,371,548
Total current assets	10,698,651	10,794,469
Furniture, fixtures and equipment, net	11,265	10,024
Intangibles, net	155,255	178,636
Right of use assets finance lease	2,511	8,998
Right of use assets operating lease	283,086	355,235
Other assets	24,150	24,150
Total assets	11,174,918	11,371,512
Current liabilities:
Accrued expenses and other payables	1,267,718	1,511,717
Accrued expenses, related party	281,947	137,189
Accrued liabilities noncontrolling interest	214,000	214,000
Current portion of finance lease liabilities	3,088	10,264
Current portion of operating lease liabilities	112,955	103,427
Total current liabilities	3,757,785	3,076,713
Non-current portion of finance lease liabilities	0	434
Non-current portion of operating lease liabilities	195,649	281,853
Total liabilities	3,953,434	3,359,000
Commitments and contingencies
Stockholders’ equity
Common stock, par value $0.001; authorized 100,000,000 shares; 77,709,455 shares issued and 77,676,122 shares outstanding as of September 30, 2024; 75,881,840 shares issued and 75,848,507 shares outstanding as of December 31, 2023;	77,710	75,881
Additional paid in capital	134,072,861	132,187,656
Accumulated deficit	(126,017,571)	(123,339,509)
Treasury stock, at cost, 33,333 shares	(911,516)	(911,516)
Total Milestone Scientific, Inc. stockholders' equity	7,221,484	8,012,512
Total liabilities and stockholders’ equity	11,174,918	11,371,512
Nonrelated Party [Member]
Current liabilities:
Accounts payable	1,138,060	689,604
Related Party [Member]
Current liabilities:
Accounts payable	$ 740,017	$ 410,512